284 results
Page 5 of 15
424B5
qayg7 fdkfs9cae4
29 Apr 20
Prospectus supplement for primary offering
5:23pm
S-3ASR
88tduh3r1g7c 2zbqx
29 Apr 20
Automatic shelf registration
5:18pm
S-3ASR
EX-4.1
gum0pm9ialrk9ao5j
29 Apr 20
Automatic shelf registration
5:18pm
8-K
EX-99.1
xm006tzjksa72xt3q0er
28 Apr 20
NeoGenomics Reports 11% Revenue Growth to $106 Million
8:15am
8-K
EX-99.1
g68i58cgrtmeqn9
2 Mar 20
INVESTOR PRESENTATION February 2020
5:19pm
8-K
EX-99.1
m6ugg sw3
27 Feb 20
NeoGenomics Reports 40% Revenue Growth to $107 Million
8:09am
8-K
EX-2.1
fis70vmi72jaybv7
13 Jan 20
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
4:50pm
8-K
EX-10.1
5ockwt d52u3b21h
2 Dec 19
Departure of Directors or Certain Officers
5:07pm
8-K
EX-99.1
q362mh5
31 Oct 19
INVESTOR PRESENTATION October 2019
12:00am
8-K
EX-99.1
ywmdh8sisknh2c5s
29 Oct 19
NeoGenomics Reports 51% Revenue Growth to $105 Million
7:38am
8-K
EX-10.2
bomhugo ihp6ylg
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-10.3
ich2dewqzlf e4bx106
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-99.1
nly ten2u
2 Aug 19
Regulation FD Disclosure
12:41pm